$NMRA

$0.39 +$0.01 (3.56%) Close

$NMRA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 187.9M shares outstanding

Who owns NMRA?

By type of holder

Institutions 40.1% Insiders 59.4% Everyone else 0.5%

Concentration Top 10 holders own 180.2%

Kristina Burow 18.1% · Keith Crandell 18.0%

Institutional ownership

40.1%

+2.6 pts vs last qtr

Institutional holders

110

-4 vs last qtr

Net shares bought

+5.0M

by institutions in Q2 2026

New / sold out

28 / 32

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

BlackRock, Inc. +5.7M
Orbimed Advisors LLC NEW +2.1M

Biggest sellers in Q2 2026

Perceptive Advisors LLC SOLD OUT −5.1M
Millennium Management LLC −2.2M

Who is planning to sell?

Notices of proposed sale, last 12 months

$390K

5 notices from 5 people

Shares covered

138.1K

0.07% of the company

Arranged in advance

80%

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Aurora Family Trust Director 10b5-1 $307K
Berns Paul L Officer $34.5K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2022–FY2025

+500.5%

+81.77% a year

Each share's claim on the business

−83.3%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $95.4M

over 4 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years84% Under 1 year16%

Quarterly turnover

26.2%

of institutional shares changed hands

Top 10 managers, median time held

2.8 years

Super Investors

Investment managers reporting NMRA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
SL Siren, L.L.C.	8.5M	4.52%	Unchanged	2024	0.3%
Shares held by quarter Peak holding8.5M (Q1'26) Change over 8 quarters+5.9M Share of the company4.520% Siren, L.L.C.'s full portfolio →
B BlackRock, Inc.	7.8M	4.15%	+5.7M (+279.3%)	2023	0.0%
Shares held by quarter Peak holding7.8M (Q2'26) Change over 8 quarters+1.6M Share of the company4.150% BlackRock, Inc.'s full portfolio →

Siren, L.L.C.

8.5M

% of company

4.52%

Change vs last qtr

Unchanged

Held since

2024

BlackRock, Inc.

7.8M

% of company

4.15%

Change vs last qtr

+5.7M (+279.3%)

Held since

2023

28 more super investors behind a free account

See every manager holding Neumora Therapeutics Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting NMRA on Form N-PORT; together they hold 7.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$5.84M	3.4M	1.83%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$4.26M	2.5M	1.33%	0.01%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$5.84M

% of company

1.83%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$4.26M

% of company

1.33%

% of the fund

0.01%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Neumora Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
KB Kristina Burow 5%+ holder 13D · 18.7%	34.0M	18.08%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company18.080% Disclosed stake13D · 18.7% View the 13D/G filing →
KC Keith Crandell 5%+ holder 13D · 18.6%	33.8M	18.01%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company18.010% Disclosed stake13D · 18.6% View the 13D/G filing →

Kristina Burow

5%+ holder13D · 18.7%

34.0M

% of company

18.08%

Change vs last qtr

—

Held since

—

Keith Crandell

5%+ holder13D · 18.6%

33.8M

% of company

18.01%

Change vs last qtr

—

Held since

—

21 more holders behind a free account

See every insider and 5%+ holder of Neumora Therapeutics Inc.

Comments